MED Past Earnings Q&A
What was the best and worst MED past earnings results?
For Medifast, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?
The highest MED past earnings result in our data set was 3.960/share posted in Q2 2021, while the lowest was in Q4 2012 when MED posted 0.13/share.
The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when MED reported 0.45B in revenue, while the quarter with the lowest revenue in our data set was Q4 2015 at 61.31M of revenue.
There are 42 MED past earnings results in our data set.
On this page we presented the MED past earnings date information for Medifast. Reviewing that
MED Past Earnings
for the company, we see that the highest past earnings result in our data set was in Q2 2021, when MED posted adjusted EPS of 3.960/share. Meanwhile the lowest MED past earnings result was in Q4 2012, when MED posted adjusted EPS of 0.13/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when MED reported 0.45B in revenue, while the smallest revenue quarter was Q4 2015 when MED reported 61.31M in revenue.
Any self directed investor doing their due diligence on MED or any other given stock can benefit from
researching all of the Medifast past earnings — and here, we present each quarter's result all together
on one page for easy comparison. Studying this information can help when projecting future earnings, as well
as determining whether the past earnings trajectory justifies the current stock value.
That's why we bring you PastEarnings
.com to make it easy for investors to investigate
Medifast past earnings, or the past earnings information for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for earnings
surprises history (beat/miss data) as well as next earnings dates for MED. Thanks for visiting, and the next
time you need to research MED past earnings
or those of another stock, we hope you'll think of our site, as your
go-to past earnings research resource of choice.